Researchers analyzed whether age and BMI impacted the value of serum neurofilament light chain for predicting demyelinating events in relapsing MS.
Read More
Do you remember the MS research presented at ACTRIMS 2024? Test your knowledge now and see how you rank!
Read More
A curated eBook featuring ACTRIMS studies, findings, and expert opinions.
Read More
SDOH play a pivotal role in shaping the landscape of neurologic diseases and outcomes.
Read More
Researchers discovered spinal cord lesions were strongly associated with clinical disease milestones even in later stages of MS.
Read More
Researchers analyzed whether age and BMI impacted the value of serum neurofilament light chain for predicting demyelinating events in relapsing MS.
Read More
Researchers investigated the impact of mesenchymal stem cell injections on cognition, function, and biomarkers for neuroinflammation and neurodegeneration.
Read More
Study results support the use of portable MRI in creating quality imaging for use in assessing patients with MS.
Read More
Study findings underscore the existence of disparities in geographic access to neurologic care for MS.
Read More
A recent study led by Philip De Jager, MD, PhD, marked a significant milestone in understanding the clinical heterogeneity of MS outcomes.
Read More
The latest news from ACTRIMS Forum 2024 focused on multiple sclerosis, including abstracts, features, and helpful conference information.
Read More
The ACTRIMS Forum 2024 Kenneth P. Johnson Memorial Lecture, “Pioneering B-Cell Therapies,” will be given by Anne H. Cross, MD.
Read More
ACTRIMS Forum 2024 launches with Session 1: “Emerging Concepts in MS,” composed of presentations by Young Investigators selected from submitted abstracts.
Read More
Take a little time during ACTRIMS Forum 2024 to explore The Square, a dynamic neighborhood offering more than 50 shops and restaurants as well as local events.
Read More
